Farallon Capital Management LLC Invitae Corp Transaction History

Farallon Capital Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 16, 2020	SELL	$28.43 - $44.67 $1.79 Million - $2.82 Million	-63,056 Reduced 9.6%	593,472 $25.7 Million
Q2 2020 Aug 14, 2020	SELL	$11.71 - $30.29 $14.3 Million - $36.9 Million	-1,218,772 Reduced 64.99%	656,528 $19.9 Million
Q1 2020 May 15, 2020	BUY	$7.64 - $27.5 $957,292 - $3.45 Million	125,300 Added 7.16%	1,875,300 $25.6 Million
Q4 2019 Feb 13, 2020	BUY	$15.02 - $20.57 $6.76 Million - $9.26 Million	450,000 Added 34.62%	1,750,000 $28.2 Million
Q3 2019 Nov 14, 2019	BUY	$18.85 - $27.5 $7.54 Million - $11 Million	400,000 Added 44.44%	1,300,000 $25.1 Million
Q2 2019 Aug 14, 2019	BUY	$17.37 - $26.27 $10.4 Million - $15.8 Million	600,000 Added 200.0%	900,000 $21.2 Million
Q1 2019 May 15, 2019	BUY	$10.65 - $25.75 $3.2 Million - $7.73 Million	300,000 New	300,000 $7.03 Million

1.92M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Farallon Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Farallon Capital Management LLC with notifications on news.